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http:WHAT THIS PAPER ADDS
This study demonstrates that pre-operative brain white matter damage assessed with diffusion tensor imaging is
associated with poor outcome in patients with peripheral arterial disease undergoing infrainguinal surgical
revascularization. The relationship between peripheral arterial disease and other comorbidities is complex and
lower brain white matter fractional anisotropy values may reﬂect worse overall cardiorespiratory and metabolic
status in these patients. Diffusion tensor imaging of the brain may have value in risk stratiﬁcation in this patient
group.Objective: Peripheral arterial disease (PAD) is a systemic atherosclerotic syndrome with high post-operative
morbidity and mortality. Fractional anisotropy (FA), an index measured by magnetic resonance diffusion tensor
imaging (DTI), has been shown to be exceedingly sensitive to microstructural damage in brain white matter
tracts. It is hypothesized that pre-operative white matter damage is more extensive in PAD patients scheduled for
vascular surgery who experience an adverse long-term outcome.
Methods: Preoperative FA values were obtained in 24 consecutive PAD patients (age >40 years) scheduled for
elective infrainguinal revascularization surgery and in 15 healthy age matched participants. All patients had their
clinical history taken and underwent physical examination and laboratory tests. After surgery, patients were
followed for a median of 52 months (range 40e63) and major adverse cardiovascular and cerebrovascular events
(MACCE) were recorded.
Results: There were no statistically signiﬁcant differences in baseline demographic or clinical variables between
the MACCE group and the non-MACCE group. During follow up, eight PAD patients suffered a MACCE and they
had lower FA values than patients without MACCE or healthy controls (mean  SD 0.370  0.017 vs.
0.392  0.023 vs. 0.412  0.018, p ¼ .036 and p ¼ .00007, respectively). Voxelwise analysis of the FA data
revealed diffuse spatial distribution of white matter damage in PAD patients. There was no statistically signiﬁcant
association between the FA values and other clinical variables.
Conclusion: Microstructural white matter damage was associated with poor outcome in PAD patients with
claudication requiring surgical revascularization, and its extent may have clinical value in risk stratiﬁcation.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Peripheral arterial disease (PAD) is a systemic atherosclerotic
syndrome with high morbidity and mortality.1,2 It has beenof original article: http://dx.doi.org/10.1016/j.ejvs.2014.10.015
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//dx.doi.org/10.1016/j.ejvs.2014.08.025estimated to affect approximately 20% of adults over 55
years of age in Europe and North America.3 Most patients
with PAD suffer from multiple comorbidities including dia-
betes, hypertension,4 and obstructive sleep apnea (OSA),5
and PAD is also known to be a risk factor for cerebral
infarction.6 Not surprisingly, patients undergoing surgical
treatment of lower extremity atherosclerotic disease have
signiﬁcant mid-term mortality because of this heavy co-
morbidity burden.7,8
There is evidence that PAD is associated with small artery
disease of the brain.9 The imaging manifestations of small
688 S. Virtanen et al.vessel disease on conventional magnetic resonance imaging
(MRI) are lacunar infarctions and white matter lesions.
However, conventional MRI is unable to demonstrate the
whole extent of white matter pathology; previous studies
with diffusion tensor imaging (DTI) have shown that sub-
stantial microstructural white matter damage also occurs in
areas that appear normal on conventional MRI,10 and that
changes in white matter microintegrity precede the devel-
opment of lesions seen with conventional MRI.11 DTI is a
recently established MRI technique, which can be used to
assess the microstructural integrity of brain white matter
tracts with good sensitivity. The method permits acquisition
of quantitative measurements such as fractional anisotropy
(FA), which represents the directionality of water diffusion
in white matter.
The purpose of this prospective follow up study was to
assess microstructural white matter damage in PAD patients
needing surgical revascularization. It is hypothesized that
pre-operative white matter damage quantiﬁed with DTI is
more extensive in those patients who experience an adverse
long-term outcome. Correlation of several clinical variables
with brain white matter FA values was also examined.
Additionally, the difference in FA values between PAD pa-
tients and healthy control participants was investigated.
PATIENTS AND METHODS
Patients
This study is a part of the BAROSLEEP project (ClinicalTrials.
gov identiﬁer: NCT00712946), which is a large prospective
study of PAD patients. The medical ethics committee of the
hospital district of Southwest Finland approved the study
protocol.
Patients in this study consist of a subgroup of PAD patients
previously described in another study of the BAROSLEEP
project.5 Of the original 82 patients with PAD over 40 years
of age scheduled for elective infra-inguinal revascularization
surgery, MRI of the brain was performed on 24 consecutive
patients between August 2008 and September 2010. Fifteen
healthy, age matched control participants were also imaged.
The control participants were recruited mainly from the
hospital staff and had no known vascular or neurological
disease. Exclusion criteria for patients were previously
diagnosed obstructive sleep apnea syndrome, congestive
heart failure, atrial ﬁbrillation or any other non-sinus
rhythm, inability to cooperate, immobility, end stage renal
disease, history of coronary bypass within 3 years, or other
major surgery within 3 months of enrolment. All patients
had their clinical history taken and underwent physical ex-
amination and laboratory tests. To assess previously undi-
agnosed obstructive sleep apnea (OSA), all participants
underwent an overnight polysomnography, and apnea-
hypopnea indices (AHI) were calculated according to a pre-
viously described protocol.5 After surgery, patients were
followed for a median of 52 months (range 40e63). Patients
were routinely seen at the outpatient ward 6 weeks and
1 year after the operation, followed by annual contacts
by phone, and data on major adverse cardiovascular andcerebrovascular events (MACCE) were retrieved from hos-
pital records. MACCE was deﬁned as cardiac death, acute
myocardial infarction (AMI), ischemic or hemorrhagic stroke,
coronary revascularization or hospitalization caused by un-
stable angina pectoris (UAP). Presence of AMI was classiﬁed
according to the third universal deﬁnition.12 According to
these criteria, patients with PAD were divided into two
groups: patients with MACCE and patients without MACCE.
MRI data acquisition, image processing, and analysis
Diffusion tensor imaging and conventional MRI were per-
formed on a 3.0T Siemens Verio scanner (Siemens Medical
Systems, Erlangen, Germany) with a head coil.
The imaging protocol consisted of the following
sequences:
 An axial T2-weighted turbo spin echo (TSE) sequence
(repetition time (TR) 5210 ms; echo time (TE) 96 ms;
section thickness 4.0 mm; intersection gap 1.2 mm;
acquisition matrix 512  512; ﬁeld of view (FOV)
220 mm).
 A sagittal 3D T2 ﬂuid-attenuated inversion recovery
(FLAIR) TSE sequence (TR 5000 ms; TE 395 ms;
inversion time (TI) 1800 ms; section thickness 1.0 mm;
intersection gap 0 mm; acquisition matrix 256  256;
FOV 250 mm).
 A sagittal 3D T1-weighted gradient echo sequence (TR
1900 ms; TE 221 ms; TI 900 ms; ﬂip angle 9; section
thickness 1.0 mm; intersection gap 0 mm; acquisition
matrix 256  256; FOV 250 mm).
 An axial DTI sequence (TR 6100 ms; TE 100 ms; number
of gradient directions 20; b-values 0 s/mm2 and 1000 s/
mm2; section thickness 3.0 mm; intersection gap 0 mm;
acquisition matrix 128  128; FOV 250 mm).
The structural MRI data were reviewed by two neurora-
diologists (SV, RP) to rule out major intracranial lesions
(tumors, large old infarcts, etc.). Analysis of the fractional
anisotropy data was performed using the tract-based spatial
statistics (TBSS)13 tool of the FMRIB Software Library14,15
toolbox. In the image analysis, raw diffusion data were
corrected for the effects of eddy currents. The FA images
were calculated and automatic brain extraction was per-
formed. Thereafter all participants’ FA images were aligned
into a common space by means of non-linear registration
and the aligned FA images were averaged to create a mean
FA image of all participants. The mean FA image was thin-
ned to create a mean FA skeleton, which represents the
centers of all tracts common to the group. This mean FA
skeleton was thresholded at FA value 0.2, thus suppressing
areas of very low FA. Aligned FA images of each participant
were then projected onto this skeleton, thus creating a
skeletonized and aligned FA map for each participant.
Finally, the mean FA values of each participant’s skeleton-
ized FA maps were then automatically measured to obtain a
global FA value for each participant. To assess the spatial
distribution of the hypothesized white matter damage,
voxelwise analysis between groups was also performed.
Table 1. Baseline demographic characteristics of the three groups and clinical data of the patient groups.
Patients with MACCE
(n ¼ 8)
Patients without MACCE
(n ¼ 16)
Healthy control participants
(n ¼ 15)
p
Age (years) 69  6.5 69  7.8 67  6.1 .76
Male sex (n) 4 (50%) 11 (69%) 5 (33%) .14
Hypertension (n) 8 (100%) 15 (94%) N/A 1.00
CAD (n) 3 (38%) 4 (25%) N/A .65
Metabolic syndrome (n) 6 (75%) 7 (44%) N/A .21
Diabetes (n) 4 (50%) 5 (31%) N/A .41
BMI (kg/m2) 27.4  5.1 26.5  4.3 N/A .63
Smoker (n) 3 (38%) 10 (63%) N/A .39
Critical ischemia (n) 0 (0%) 1 (6%) N/A 1.00
ABI (ratio) 0.46  0.21 0.59  0.20 N/A .16
PAD history (years) 3.5  3.6 3.8  4.4 N/A .89
AHI 29  16.7 23  22.7 N/A .55
General anesthesia (n) 1 (13%) 1 (6%) N/A 1.00
Spinal anesthesia (n) 7 (88%) 15 (94%) N/A 1.00
Cross-over reconstruction (n) 0 (0%) 3 (19%) N/A .53
Femoropopliteal reconstruction (n) 6 (75%) 8 (50%) N/A .39
Endarterectomy (n) 2 (25%) 4 (25%) N/A 1.00
Patch angioplasty (n) 0 (0%) 1 (6%) N/A 1.00
Duration of operation (min) 205  57 200  49 N/A .82
Cholesterol (mmol/L) 4.8  1.4 4.5  0.9 N/A .58
LDL (mmol/L) 2.4  0.7 2.3  0.9 N/A .79
HDL/Chol (%) 27.9  9.8 37.1  13.5 N/A .10
Triglycerides (mmol/L) 2.4  1.7 1.4  1.0 N/A .08
Data are shown as mean  standard deviation or number (percentage) of participants. N/A ¼ not applicable. CAD ¼ coronary artery
disease; BMI ¼ body mass index; ABI ¼ ankle-brachial index; AHI ¼ apnea-hypopnea index; LDL ¼ low density lipoprotein; HDL/
Chol ¼ high density lipoprotein/total cholesterol ratio. Comparisons between the three groups were performed with one-way analysis
of variance (continuous variables) and Fisher-Freeman-Halton test (categorical variables). Comparisons between the two patient groups
were performed with Student t test (continuous variables) and Fisher’s exact test (categorical variables).
Brain MRI in PAD Patients 689Statistics
The Shapiro-Wilk W test was used to test for normality of all
continuous variables.
Differences in the demographic data between the three
groups were analyzed with one-way analysis of variance
(ANOVA) for continuous variables and the Fisher-Freeman-
Halton test for categorical variables. Differences in the
clinical data between the two PAD patient groups were
analyzed with Student two-sample t test for continuous
variables and Fisher’s exact test for categorical variables.
Differences in global FA values between the three groups
were analyzed using one-way analysis of covariance
(ANCOVA). Preliminary checks were conducted to ensure
that the assumptions of homogeneity of variances and
homogeneity of regression slopes were met. As age is
known to have negative correlation with FA values in adult
population over 30 years of age,1618 it was included as a
covariate in the analysis even though the groups were
closely age-matched. Pairwise post hoc tests between the
groups were adjusted for multiple comparisons with the
Sidak method.
Any p values less than .05 were considered statistically
signiﬁcant in all analyses. The analyses were performed
using the SPSS software package (Version 21; IBM Corpo-
ration, Armonk, NY, USA).
Voxelwise analysis of the FA data was used to visualize
differences in local FA values between the groups, thusassessing the spatial distribution of microstructural brain
white matter damage in PAD patients. This analysis was
performed with permutation-based inference (10,000 per-
mutations) using the threshold-free cluster enhancement
method19 and correction for multiple comparisons with
alpha level of p less than .05. Age was used as a covariate in
the voxelwise analysis. The randomize tool of the FSL
toolbox was used in this analysis. TBSS with permutation
statistics has been shown to be a sensitive and powerful
analysis method even with small sample sizes.20
RESULTS
There were no statistically signiﬁcant differences in de-
mographics between the MACCE group, non-MACCE group,
and healthy control participants. Also, the clinical features,
type of anesthesia, type of surgery or operation duration
did not signiﬁcantly differ between the two patient groups.
Baseline demographic characteristics and clinical features of
the groups are shown in Table 1. Only one PAD patient
suffered from critical ischemia, while the rest of the pa-
tients were operated on for claudication. During follow up,
eight PAD patients suffered a MACCE (3 cardiac deaths, 1
stroke, 3 AMIs, 1 UAP).
One-way ANCOVA showed a statistically signiﬁcant dif-
ference in global FA values between the three groups
(p ¼ .00009). In pairwise post hoc comparisons, patients
with MACCE had signiﬁcantly lower global FA values
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(0.392  0.023) and healthy control participants
(0.412  0.018) (p ¼ .036 and p ¼ .00007, 95% conﬁdence
intervals (CI) for difference 0.042 to 0.001 and 0.061
to 0.020, respectively). The global FA values of patients
without MACCE were also signiﬁcantly lower than those of
healthy controls (p ¼ .026; 95% CI for difference 0.036
to 0.002) (Fig. 1). None of the demographic or clinical
variables listed in Table 1 showed signiﬁcant association
with global FA values when tested separately (data not
shown), and therefore multivariate analysis was omitted.
Voxelwise comparison between the MACCE group and
the non-MACCE group showed large areas of lower FA
values in the MACCE group. The areas with lower FA values
were mainly in the supratentorial white matter and
mesencephalon, whereas in the cerebellar white matter
there was no statistically signiﬁcant difference between the
groups (Fig. 2). The non-MACCE group also had large areas
of lower FA when compared with the control group (data
not shown). As with global FA values, voxelwise analysis
also showed no statistically signiﬁcant association between
local FA values in any brain area and the severity of OSA or
other clinical variables.
Voxelwise analysis of the FA data between all patients
and healthy control participants also revealed extensive
areas of signiﬁcantly lower FA values in the patient group
(p < .05, corrected for multiple comparisons). The distri-
bution of white matter damage in the PAD patient group
was diffuse, including both supratentorial and infratentorial
white matter with no clear predilection for speciﬁc areas
(Fig. 3).Figure 1. A Tukey box plot representing differences in global FA
values between the three groups. Pairwise p values are adjusted
for multiple comparisons with the Sidak method.DISCUSSION
The main ﬁnding of the present study was that patients
who had adverse events during the follow up period had
lower pre-operatively measured FA values than patients
without serious adverse events. Secondly, patients with
PAD in general seemed to have white matter injury, as
evidenced by lower brain white matter FA values than
healthy participants. There was no correlation between
other clinical variables with FA values.
To the authors’ knowledge this is the ﬁrst prospective
follow up study using DTI of the brain as a prognostic
marker in PAD patients. Earlier studies have shown that
lower FA values measured at early phase were associated
with long-term neurocognitive impairment in patients with
traumatic brain injury, and predicted long-term motor
functional outcome after acute supratentorial intracranial
hemorrhage and poor neurological outcome at 1 year after
cardiac arrest.2124 Interestingly, the ﬁndings demonstrate
that DTI may also have prognostic value not only in patients
with neurological syndromes but also in a population with
chronic, systemic disease. The spatial distribution of
microstructural white matter alterations in current patients
was very widespread with no clear predisposition to speciﬁc
parts of the brain. The authors consider this to reﬂect the
diffuse nature of small vessel disease of the brain in this
patient group.
The relationship between microstructural white matter
damage, PAD, and comorbidities in this patient group is
complex, as most patients with PAD suffer from multiple
comorbidities that also affect white matter microintegrity.
Numerous studies have shown that the loss of white matter
microintegrity demonstrated with DTI is associated with
arterial hypertension, elevated pulse pressure, diabetes,
metabolic syndrome, and PAD itself.9,2531 Therefore, lower
white matter FA values may reﬂect worse overall cardio-
respiratory and metabolic status of patients. This could
explain current results where PAD patients with lower white
matter FA values had poorer long-term outcome with
higher incidence of major adverse cardiac events.
There are some limitations in this study. First, the small
sample size limits the statistical power in detecting differ-
ences in some of the possible explanatory variables other
than FA between the patient groups; however, the purpose
of this pilot study was to obtain information about the as-
sociation of microstructural white matter damage with poor
outcome in patients with PAD, and clinical variables were
included mainly to demonstrate the comparability of the
patient groups. Second, because of the exclusion criteria,
the patients in this study represent a selected subgroup
PAD patients with signiﬁcantly fewer comorbidities such as
renal or heart failure, and only one patient suffering from
critical ischemia. Thus, the present results are not directly
generalizable to an unselected population of patients with
PAD. Unselected patient populations should be used in
further studies. Third, many DTI analysis methods, including
TBSS, still have some problems in analyzing small ﬁber
tracts and regions with crossing white matter ﬁbers or tract
Figure 2. Results of the voxelwise TBSS analysis of FA between PAD patients with MACCE and patients without MACCE overlaid on a
standard MNI152 T1-weighted image. Areas of white matter damage indicated by signiﬁcantly lower FA values (p < .05, corrected for
multiple comparisons) in the MACCE group are shown in red-yellow. Areas of no signiﬁcant difference between the groups are shown in
green.
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entirely reliable. However, the strength of this study is the
use of operator-independent and unbiased analysis
methods for the DTI data. In recent years, the TBSS method
has become almost the de facto standard for voxel-based
analysis of diffusion data. The method was developed toFigure 3. Results of the voxelwise TBSS analysis of FA between all p
T1-weighted image. Areas of white matter damage indicated by signiﬁc
in the patient group are shown in red-yellow. The unaffected areas ofmitigate problems in aligning FA images of multiple par-
ticipants with each other and has been shown to perform
better than conventional voxel-based morphometry
methods.13 Although the TBSS method includes multiple
stages of image processing, it has been shown to have very
good repeatability, with inter-session coefﬁcient of variationatients and control participants overlaid on a standard MNI152
antly lower FA values (p < .05, corrected for multiple comparisons)
the FA skeleton are shown in green.
692 S. Virtanen et al.in FA values ranging from 3% to 5%, which is considerably
less than with region-of-interest (ROI)-based analysis.13
Because of this, manual region-of-interest (ROI)-type anal-
ysis was not used, which is also known to have some
problems with intra- and inter-rater variability and repeat-
ability.32 Even small variations in ROI size or position may
lead to signiﬁcant differences in DTI measurements. These
problems are avoided by using co-registration of the FA
images between participants, automated measurements,
and voxelwise analysis.
The main clinical implication of this study is in providing a
possible new tool for long-term risk stratiﬁcation in patients
with PAD undergoing vascular surgery. Although patients
with PAD undergoing vascular surgery have a poor prog-
nosis in general because of serious systemic atherosclerosis,
it has been difﬁcult to estimate the risk of serious events
(e.g. stroke, AMI, and death) in an individual patient. The
present results show that patients with microstructural
brain white matter damage represent a speciﬁc high-risk
group even without the presence of clinical stroke, and
measures should be taken to identify such patients. Before
per patient risk assessment is possible, however, normal
values for different age groups should be obtained indi-
vidually in each center, as FA values acquired with different
MRI scanners or protocols may not be directly comparable.
Further studies are needed to clarify the relationship be-
tween white matter microintegrity and the risk of major
adverse cardiovascular events. These studies should be
performed with larger patient groups. Patient cohorts
should be unselected, with less strict exclusion criteria and
include also patients with more severe manifestation of
PAD than claudication. In addition to DTI, there are also
other even more advanced methods for producing and
analyzing diffusion data, like diffusion kurtosis imaging
(DKI)33 and high-angular-resolution diffusion imaging
(HARDI) with constrained spherical deconvolution (CSD).34
These methods could be used to analyze white matter in
PAD patients with even greater accuracy.
CONCLUSION
Microstructural white matter damage may be associated
with poor outcome in patients with claudication requiring
surgical revascularization, and its extent may have clinical
value in risk stratiﬁcation. Patients with claudication have
lower white matter FA values than healthy participants. The
pilot nature of this study with its small sample size means
that further studies with larger patient groups are war-
ranted to conﬁrm its ﬁndings.
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